Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Kirk

Showing results (101-110 of 171) with videos related to

Pageof 18
Sort By:
BMC Infectious Diseases|October 7, 2021
Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort studyChristian Kraef, Adrian Bentzon, Alexander Panteleev, et al.
Antiviral Therapy|December 15, 2010
HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study, Rainer Weber, Caroline Sabin, et al.
AIDS (London, England)|May 11, 2010
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study, Colette Smith, Caroline A Sabin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2010
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?, Amanda Mocroft, Peter Reiss, et al.
Circulation|February 4, 2009
Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)Signe W Worm, Stephane De Wit, Rainer Weber, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2013
Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D studyCaroline A Sabin, Lene Ryom, Helen Kovari, et al.
Journal of the International AIDS Society|June 12, 2021
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µLAndrew Atkinson, Jose M Miro, Amanda Mocroft, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 15, 2010
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs studyNina Friis-Møller, Rodolphe Thiébaut, Peter Reiss, et al.
AIDS (London, England)|October 15, 2014
Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord, Sara Lodi, Rosemary Dray-Spira, et al.
BMC Medical Education|December 13, 2023
The postgraduate medical educational climate assessed by the Danish Residency Educational Climate Test (DK-RECT): a validation and cross-sectional observational studyRikke Borre Jacobsen, Klarke Boor, Karl Bang Christensen, et al.
Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:
Pageof 18
BMC Infectious Diseases|October 7, 2021
Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort studyChristian Kraef, Adrian Bentzon, Alexander Panteleev, et al.
Antiviral Therapy|December 15, 2010
HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study, Rainer Weber, Caroline Sabin, et al.
AIDS (London, England)|May 11, 2010
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study, Colette Smith, Caroline A Sabin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2010
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?, Amanda Mocroft, Peter Reiss, et al.
Circulation|February 4, 2009
Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)Signe W Worm, Stephane De Wit, Rainer Weber, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2013
Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: the D: A: D studyCaroline A Sabin, Lene Ryom, Helen Kovari, et al.
Journal of the International AIDS Society|June 12, 2021
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µLAndrew Atkinson, Jose M Miro, Amanda Mocroft, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 15, 2010
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs studyNina Friis-Møller, Rodolphe Thiébaut, Peter Reiss, et al.
AIDS (London, England)|October 15, 2014
Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord, Sara Lodi, Rosemary Dray-Spira, et al.
BMC Medical Education|December 13, 2023
The postgraduate medical educational climate assessed by the Danish Residency Educational Climate Test (DK-RECT): a validation and cross-sectional observational studyRikke Borre Jacobsen, Klarke Boor, Karl Bang Christensen, et al.
Pageof 18